美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ultra納斯達克生物科

113.95

+4.964.55%

成交量：1,617

成交額：18.30萬

市值：9,571.80萬

市盈率：- -

高：113.95

開：113.00

低：113.00

收：108.99

52周最高：126.40

52周最低：55.34

股本：84.00萬

流通股本：84.00萬

量比：0.55

換手率：0.19%

股息：0.33

股息率：0.29%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

吉利德科學(GILD)股票8月5日盤中下跌3.96%：關鍵驅動因素揭曉

TradingKey中文

道瓊斯指數漲439點，安進與英偉達股價領升大盤。

安進上調全年業績預期且第二季度業績超預期，股價飆升至歷史新高

券商觀點：吉利德艾滋病業務實力蓋過長期競爭擔憂

行業觀察：安進憑藉重磅藥物、生物類似藥及蓄勢待發的研發管線持續積聚勢頭

吉利德科學高管：Q2艾滋病治療市場趨軟，ACA税收補貼取消致部分民眾失去醫保覆蓋

吉利德科學高管：今年暫無計劃進行大規模併購交易

安進二季度強勁藥品銷售，上調預期，將終止早期減肥藥研發

环球市场播报

吉利德科學於2026年8月4日公布了2026年第二季度財務業績。總收入按年增長10%達到78億美元主要得益於不包括Vek

安進高管表示，預計第三季度運營支出將出現顯著的按月增長。

安進高管重申：2026年資本支出預計約26億美元，用於擴大產能，含Maritide上市準備

安進高管：Q2資本支出達5億美元，聚焦全美製造基地投資——電話會議紀要

安進高管在電話會議上表示，第二季度資本支出達5億美元，主要受美國各地生產基地投資推動。

吉利德高管在電話會議中宣佈：全年HIV業務增長預期上調至9%-10%，此前指引為8%

吉利德高管：距FDA PDUFA日期僅剩五個月，Anito-Cel細胞療法上市籌備工作已全面啓動

吉利德科學第二季度調整後每股收益-6.75美元，高於IBES預估-7.24美元

安進(AMGN)股票8月4日收盤上漲3.03%：關鍵驅動因素揭曉

TradingKey中文

吉利德科學：季度調整後每股虧損6.75美元，反映近期收購帶來的每股9.08美元知識產權研發及税務支出

安進第二季度銷售額增長9%，利潤超出華爾街預期

吉利德第二季度銷售額增長8%，超出華爾街預期

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/BIB/news?page=5"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BIB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","market":"US","secType":"STK","nameCN":"Ultra納斯達克生物科","latestPrice":113.95,"timestamp":1789659921263,"preClose":108.9876,"halted":0,"volume":1617,"delay":0,"changeRate":0.045531785267314835,"floatShares":840000,"shares":840000,"eps":0,"marketStatus":"交易中","change":4.9624,"latestTime":"09-17 11:52:47 EDT","open":113,"high":113.95,"low":113,"amount":183014.996472,"amplitude":0.008717,"askPrice":114.22,"askSize":100,"bidPrice":113.92,"bidSize":120,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789675200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":108.9876,"sharesOutstanding":1040000,"nav":108.5525,"aum":91184100,"dividendRate":0.00287,"bidAskSpread":0.002695,"preHourTrading":{"tag":"盘前","latestPrice":107.01,"preClose":108.9876,"latestTime":"08:07 EDT","volume":8,"amount":856.08,"timestamp":1789646849130,"change":-1.9776,"changeRate":-0.018145,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":108.37,"preClose":108.9876,"latestTime":"19:44 EDT","volume":29,"amount":3116.2656,"timestamp":1789602249698,"change":-0.6176,"changeRate":-0.005667,"amplitude":0},"volumeRatio":0.548999,"impliedVol":0.3745,"impliedVolPercentile":0.0637},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","floatShares":840000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.548999,"shares":840000,"dividePrice":0.327,"high":113.95,"amplitude":0.008717,"preClose":108.9876,"low":113,"week52Low":55.34,"pbRate":"--","week52High":126.399,"institutionHeld":0,"latestPrice":113.95,"committee":0.090909,"eps":0,"divideRate":0.00287,"volume":1617,"delay":0,"ttmEps":0,"open":113,"prevYearClose":79.7794,"prevWeekClose":109.7741,"prevMonthClose":116.5968,"prevQuarterClose":100.74,"fiveDayClose":109.5953,"twentyDayClose":126.2177,"sixtyDayClose":89.7431},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIB\",params:#limit:5,,,undefined,":[{"date":"2026-03-25","symbol":"BIB","amount":0.00714,"announcedDate":"2026-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-25","defaultRemindTime":1774445400000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-25","currency":"USD","dateTimestamp":1774411200000,"payDate":"2026-03-31"},{"date":"2025-12-24","symbol":"BIB","amount":0.134637,"announcedDate":"2025-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-24","defaultRemindTime":1766586600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-24","currency":"USD","dateTimestamp":1766552400000,"payDate":"2025-12-31"},{"date":"2025-09-24","symbol":"BIB","amount":0.180541,"announcedDate":"2025-09-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-24","defaultRemindTime":1758720600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-24","currency":"USD","dateTimestamp":1758686400000,"payDate":"2025-09-30"},{"date":"2025-06-25","symbol":"BIB","amount":0.170576,"announcedDate":"2025-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-25","defaultRemindTime":1750858200000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-25","currency":"USD","dateTimestamp":1750824000000,"payDate":"2025-07-01"},{"date":"2025-03-26","symbol":"BIB","amount":0.130939,"announcedDate":"2025-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-26","defaultRemindTime":1742995800000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-26","currency":"USD","dateTimestamp":1742961600000,"payDate":"2025-04-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIB\",market:\"US\",,,undefined,":[{"executeDate":"2022-12-22","recordDate":"2022-12-23","paymentDate":"2022-12-30","value":0.019852,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-28","value":0.038393,"currency":"USD"},{"executeDate":"2024-03-20","recordDate":"2024-03-21","paymentDate":"2024-03-27","value":0.040324,"currency":"USD"},{"executeDate":"2024-06-26","recordDate":"2024-06-26","paymentDate":"2024-07-03","value":0.26476,"currency":"USD"},{"executeDate":"2024-09-25","recordDate":"2024-09-25","paymentDate":"2024-10-02","value":0.15285,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIB\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657252984","title":"吉利德科學(GILD)股票8月5日盤中下跌3.96%：關鍵驅動因素揭曉","url":"https://stock-news.laohu8.com/highlight/detail?id=2657252984","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657252984?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 00:16","pubTimestamp":1785946581,"startTime":"0","endTime":"0","summary":"• 吉利德科学在下调全年盈利指引后股价下跌。\n• HIV特许经营业务销售增速放缓以及肿瘤学临床结果表现平平，影响了投资者情绪。\n• 运营和研发成本增加挤压了公司的利润率。","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262078660-market-movers-gild-20260805","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673428.USD","IE00BKVL7J92.USD","IE00B19Z3581.USD","LU0882574055.USD","LU0122379950.USD","IE00B19Z3B42.SGD","LU0058720904.USD","MEDI","GILD","TMED","LU1571399168.USD","LU1674673691.USD","BK4578","BK4588","BK4532","BBH","IE0002270589.USD","BIB","LU1037948541.HKD","LU0965509283.SGD","LU2089984988.USD","IE00BZ1G4Q59.USD","BK4568","LU0114720955.EUR","LU1057294990.SGD","LU1839511570.USD","LU1066051498.USD","LU0289739699.SGD","LU1934455863.HKD","LU0234570918.USD","TBXU","IE00B7SZLL34.SGD","LU0861579265.USD","BK4566","SG9999015952.SGD","LU0965509010.AUD","IE00B3T34201.USD","LU0889565916.HKD","LU2468319806.SGD","IBBQ","BK4583","IBB","SG9999015978.USD","LU1037948897.HKD","LU1934455194.USD","BK4139","LU0109394709.USD","LU1934455277.USD","BK4550","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657552660","title":"道瓊斯指數漲439點，安進與英偉達股價領升大盤。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657552660","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657552660?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 23:52","pubTimestamp":1785945122,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SNPE","LU1400636657.SGD","NVD3.UK","IE00B5949003.HKD","TOPT","IBBQ","LU2133065610.SGD","LU1699723380.USD","IE00B19Z9505.USD","LU1861220033.SGD","NVDS","MGK","LU0354030511.USD","LU1732799900.SGD","LU0342679015.USD","LU2322448957.HKD","FTEC","LU1429558221.USD","IE000Q6AESB8.SGD","LU0868494617.USD","LU0553294199.USD","LU2065170008.USD","IE00BJJMRY28.SGD","LU2271345857.HKD","LU1791710400.SGD","LU0210528500.USD","IE00BYXW3230.USD","IE00BMPRXR70.SGD","IE00B3S45H60.SGD","LU2272731600.USD","LU0965509010.AUD","BK4534","LU0719512351.SGD","BK4139","IE0034235295.USD","TRFK","LU1880398471.USD","NVDS.UK","SG9999001424.SGD","IE00B2B36J28.USD","LU2413666699.HKD","IE00BHPRN162.USD","LU0198837287.USD","LU0133085943.USD","LU0787776722.HKD","LU0708995401.HKD","HK0000914660.USD","LU0795875169.SGD","NVDW","LU0353189763.USD","LU0494093205.USD","LU0545039389.USD","LU1548497426.USD","IE0005OL40V9.USD","LU0683600562.USD","LU0154236417.USD","SCHG","LU1868836591.USD","LU2125909916.SGD","LU0127658192.USD","LU0210533765.USD","LU2065171311.SGD","LU1023059063.AUD","IE00BJJMRZ35.SGD","BK4599","LU2756315664.SGD","LU2602419157.SGD","LU1623119135.USD","LU0466842654.USD","VT","LU2242650005.HKD","LU1242518931.SGD","HK0000320264.USD","LU0138981039.USD","SG9999015358.SGD","LU2403377893.USD","LU2452424414.USD","IE000ITXATA3.USD","SGXZ31699556.SGD","LU1119994496.HKD","BK4592","IE00BKDWB100.SGD","LU1720051017.SGD","DGRO","SG9999014880.SGD","IE00BJT1NW94.SGD","DJIA","GRNY","NVII","LU0079474960.USD","LU1645745479.HKD","LU0345770308.USD","LU1244550221.USD","SG9999014914.USD","LU1983260115.SGD","LU1923623000.USD","LU2125154778.USD","SMH","LU1202635105.USD","LU0395794307.EUR","LU0957808578.USD","LU0528227936.USD","IETC","LU2237438978.USD","BK4550","LU1804176565.USD","UDOW","NVIW.SI","LU1551013425.SGD","BK4614","IE0034235303.USD","LU0316494557.USD","LU0557290698.USD","LU0345770993.USD","BK4566","LU2999663052.SGD","LU0109391861.USD","LU1718418525.SGD","LU1127390331.HKD","LU1674673691.USD","LU1852331112.SGD","SG9999017495.SGD","LU1629891620.HKD","LU2092627202.USD","LU0097036916.USD","LU0158827781.USD","LU2394011477.USD","FDTX","IE00BMPRXN33.USD","LU2065171402.SGD","LU0082616367.USD","LU3102509885.SGD","LU2089985449.USD","BK4605","HK0000819398.USD","LU2089283258.USD","LU0225283273.USD","LU2860962120.EUR","CHAT","LU2237443465.HKD","LU0823434583.USD","BK4549","LU0310799852.SGD","SG9999015945.SGD","ARTY","ANV","IE00BKVL7J92.USD","LU1244550577.SGD","IE00BFSS7M15.SGD","LU2097344357.USD","LU1814569148.SGD","LU1267930730.SGD","SMHX","IE0002141913.USD","LU2286300806.USD","LU2264538146.SGD","LU1989764664.SGD","TEK","LU0061474960.USD","SNVD.UK","LU2463028550.USD","LU1003077747.HKD","LU1778281490.HKD","04332","LU0081259029.USD","SG9999018857.SGD","TYLG","LU2244417387.USD","IE0034235188.USD","LU1791710582.SGD","AIFD","NVDD","DGRW","LU2433249047.HKD","CLSE","IE0004445239.USD","LU1323610961.USD","LU2361044865.SGD","IE0004086264.USD","LU1934455277.USD","LU0058720904.USD","IE0009G5SDU7.USD","LU1116320901.HKD","LU0061475181.USD","LU2487616109.SGD","LU0912757837.SGD","LU2063271972.USD","LU0353189680.USD","LU2326559502.SGD","LU0238689110.USD","LU0053666078.USD","LU1923622291.USD","LU0109392836.USD","LU0738911758.USD","LU2360107168.USD","LU1880398554.USD","LU0203202063.USD","IE000KEQY171.SGD","LU2458330169.SGD","LU1979441026.SGD","EFIV","HK0000914686.HKD","LU2361045086.USD","LU2456880835.USD","LU0128525929.USD","LU1917777945.USD","LU0820562030.AUD","LU2047632596.USD","LU2237443622.USD","LU0689626769.HKD","DVY","IE0009356076.USD","3NVD.UK","HK0000304797.USD","ILDR","BK4503","LU2237443895.HKD","LU1868836757.USD","SG9999018865.SGD","LU2265009873.SGD","LU1232071149.USD","SDOW","HK0000304805.HKD","LU2322448791.USD","BK4598","LU0234572021.USD","IE00B5TLWC47.USD","LU2505996681.GBP","LU2023250330.USD","LU2468319806.SGD","LU1983299246.USD","LU0096362180.USD","LU1720051108.HKD","SGXZ51526630.SGD","LU0788109477.HKD","BK4585","SG9999014567.USD","SGXZ80539844.SGD","LU0345768153.USD","SG9999015341.SGD","LU2931357623.SGD","SG9999000418.SGD","AIPI","WISE","LU0823414551.USD","LU0215105999.USD","IE00BQXX3D17.EUR","NULC","SG9999004303.SGD","LU2347655073.USD","LU1035773651.USD","SOXQ","JGRO","LU1496350171.SGD","IE00BJLML261.HKD","IE00B3M56506.USD","LU2237957811.SGD","LU2462591277.SGD","SGXZ81514606.USD","LU1992135399.USD","LU0109394709.USD","LU0724617625.USD","LU2430703095.HKD","LU2357125470.USD","BBH","LU1989764748.USD","SG9999014559.SGD","IE00BQXX3C00.GBP","LU0187121727.USD","IE00BMPRXQ63.HKD","LU2279689827.SGD","LU1642822529.SGD","LU2552382058.USD","LU1839511570.USD","SG9999014575.USD","LU2065169927.USD","IE0001KFT4U8.USD","BK4612","LU0011850046.USD","HK0000306701.USD","IE00BKPKM429.USD","LU1069347547.HKD","LU2290526834.HKD","LU2247934214.USD","LU2168564495.EUR",".DJI","LU0347712357.USD","BK4581","TTEQ","LU0310800379.SGD","LU2360032135.SGD","BK4527","LU1670756490.USD","AMGN","LU0251132253.USD","IE000YTNTUN2.SGD","LU0444973449.USD","LU2430703251.USD","LU2097344431.USD","LU0158827948.USD","LU0256863902.USD","07388","LU0345769128.USD","LU2471134796.USD","LU1732800096.USD","YMAX","LU1084165304.USD","LU1035775433.USD","LU0964807845.USD","LU1066053197.SGD","LU1935043536.SGD","LU2756315318.SGD","IE00BZ199S13.USD","LU0274383776.USD","LU2083900584.USD","IXN","LU0106261372.USD","LU1914381329.SGD","LU1280957306.USD","NVDG","LU2092937148.SGD","IE0003U64NQ7.SGD","LU1815336760.USD","07788","LU2106854487.HKD","THMR","LU0203201768.USD","LU1923622614.USD","IE00B4R5TH58.HKD","LU2111349929.HKD","LU2430703178.SGD","LU2491050071.SGD","LU1145028129.USD","LU0289739699.SGD","IE00BFSS8Q28.SGD","SPTE","XLI","LU2471134952.CNY","LU1803068979.SGD","SG9999015952.SGD","SHOC","LU2023250504.SGD","SOXX","LU1316542783.SGD","LU2552382132.HKD","LFGY","LU2100268510.USD","ROM","LU2108987350.USD","LU0289960550.SGD","LU0070217475.USD","LU2750360997.AUD","LU2491049909.HKD","LU0708994859.HKD","LU2462157665.USD","LU2237957902.USD","LU2272731865.HKD","LU0124676726.USD","LU0965508806.USD","LU2750360641.GBP","NVDX","LU2506951792.HKD","LU0942090050.USD","NVYY","LU2420271590.USD","DJX","LU1435385759.SGD","LU2213496289.HKD","LU0234570918.USD","LU1861215975.USD","BK4533","IE00B19Z8W00.USD","LU0965509101.SGD","BIB","LU1066051225.USD","LU2896262040.SGD","LU2125909759.SGD","LU0289739343.SGD","LU0476273544.USD","LU2148611432.USD","LU1261432733.SGD","LU0094547139.USD","IE00B4JS1V06.HKD","LU0640476718.USD","LU2089284900.SGD","LU0889565833.HKD","LU2054465674.USD","SG9999001440.SGD","IE00B1XK9C88.USD","TTXU","LU1989772923.USD","LU0175139822.USD","USXF","BK4554","LU1691799644.USD","NVDU","XLK","LU0029864427.USD","IE00BFTCPJ56.SGD","LU0069063385.USD","SG9999015986.USD","BK4141","LU0868494708.USD","LU0211328371.USD","LU2168564065.EUR","IE000W1ABFV2.USD","LU1064131342.USD","LU1244550494.USD","LU2746668974.SGD","LU2168563687.JPY","LU0823421416.USD","IE0004091025.USD","DIPS","LU1066051498.USD","LU1974910355.USD","LU2125154935.USD","ESUM","LU2552382215.SGD","LU2954938101.SGD","LU0861579265.USD","LU0170899867.USD","LU0265550946.USD","LU1868836914.USD","LU0889565916.HKD","BK4532","LU2505996509.AUD","LU0985320562.USD","BK4529","LU2125909593.SGD","LU1861127337.USD","LU2462591350.SGD","MYMmain","LU1951200564.SGD","BK4579","LU0289961442.SGD","LU0417517546.SGD","LU1988902786.USD","SG9999015978.USD","TBXU","LU0157215616.USD","LU1400636574.HKD","DDM","LU2360106780.USD","LU2249611893.SGD","LU2361044949.HKD","LU2461242641.AUD","LU1242518857.USD","LU2637965513.SGD","NVDY","LU0276348264.USD","LU0820561818.USD","LU1267930490.SGD","LU0345768740.USD","LU2242649171.HKD","NVDO","LU0642271901.SGD","NVDA","LU1037948541.HKD","IBB","VYMI","LU0072462426.USD","LU1069344957.HKD","LU1821325948.USD","LU2471134523.USD","LU0689472784.USD","VUG","LU0472753341.HKD","BK4548","IE0009355771.USD","LU1633808545.USD","SG9999002224.SGD","LU2087621335.USD","LU2237443978.SGD","IE00BZ1G4Q59.USD","LU1366333091.USD","FDN","SG9999014542.SGD","IE00B775H168.HKD","LU0979878070.USD","LU1066051811.HKD","LU2087625088.SGD","LU0882574139.USD","LU2272731782.SGD","CNEQ","NVDL","LU2077746001.SGD","LU0061474705.USD","LU2491050154.USD","LU2347655156.SGD","LU0211327993.USD","IE00BDCRKT87.USD","LU2028103732.USD","LU0511384066.AUD","HK0000306685.HKD","USD","LU0048584097.USD","IE00B775SV38.USD","LU0308772762.SGD","LU0077335932.USD","IE00B7KXQ091.USD","LU2237443382.USD","SGXZ99366536.SGD","NVDQ","LU0390134368.USD","LU2458330243.SGD","HK0000532082.HKD","LU2543165471.USD","SOXY","BK4543","LU1267930573.SGD","LU2023251221.USD","BK4588","LU1037948897.HKD","LU1935042991.SGD","DOG","BK4567","LU0057025933.USD","LU0786609619.USD","IE00BK4W5L77.USD","IE00B1BXHZ80.USD","LU1496350502.SGD","METV","LU1674673428.USD","LU1057294990.SGD","PJP","GB00BDT5M118.USD","LU0823421333.USD","LU2746668461.USD","FDVV","LU1061106388.HKD","PBE","LU1992135472.HKD","LU2125909247.SGD","AGOX","LU1934455194.USD","LU0323239441.USD","LU1989772840.SGD","LU1366192091.USD","LU2471134879.HKD","LU0265550359.USD","LU0949170772.SGD","SDY","LU0006306889.USD","LU0943347566.SGD","GAMR","SG9999014906.USD","2NVD.UK","LU0323240290.USD","LU0122379950.USD","LU1400636491.USD","LU1934455863.HKD","NVD2.UK","CMAG","LU0320765059.SGD","IE00BK4W5M84.HKD","LU0823434740.USD","LU2237443549.SGD","LU0345769631.USD","LU1551013342.USD","LU2236285917.USD","LU2381873111.SGD","HK0000320223.HKD","LU0256863811.USD","LU0957791311.USD","LU0174119429.USD","LU2417539215.USD","BK4608","SG9999002232.USD","ABFL","LU2112291526.USD","LU1116320737.USD","LU0726765562.USD","LU1868837300.USD","IE00B19Z8X17.USD","BK4551","IE00B4YYXB79.USD","LU2191332357.HKD","LU0354030438.USD","IE00BDRTCR15.USD","LU0267386448.USD","LU0107464264.USD","LU1951198990.SGD","IE00B3SWFQ91.USD","LU0823414478.USD","IE00BN29S564.USD","LU2168564149.EUR","LU1712237335.SGD","LU0444971666.USD","LU0323591593.USD","LU1815333072.USD","LU2242646821.SGD","LU0820561909.HKD","LU0965509283.SGD","LU0096364046.USD","LU2242652126.USD","LU0266013472.USD","SGXZ23171101.USD","LU0210536198.USD","DXD","LU1935043023.USD","LU0348723411.USD","LU2168564222.USD","IE00BJJMRX11.SGD","IE0004445015.USD","LU1935042488.USD","LU2357305700.SGD","LU2413666426.HKD","IE00BQXX3F31.USD","LU2294711713.HKD","NVD","LU0320765992.SGD","CHPX","LU0143551892.USD","VGT","LU2473716301.USD","LU1868837136.USD","LU2592432038.USD","LU1571399168.USD","BK4587","LU0661504455.SGD","LU2250418816.HKD","SG9999014898.SGD","VYM","LU0056508442.USD","ESLG","LU0795875086.SGD","LU0080751232.USD","LU1721428933.USD","LU2089984988.USD","IE00BJTD4V19.USD","LU1935042215.USD","FAI","LU0672654240.SGD","IE00BJTD4N35.SGD","NVDB","IE00BWXC8680.SGD","LU2211815571.USD","IE00BD6J9T35.USD","LU1153585028.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657523142","title":"安進上調全年業績預期且第二季度業績超預期，股價飆升至歷史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2657523142","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657523142?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 22:40","pubTimestamp":1785940823,"startTime":"0","endTime":"0","summary":"BUZZ-安进上调全年业绩预期且第二季度业绩超预期，股价飙升至历史新高8月5日-** 安进公司（AMGN.O）股价在早盘交易中飙升6.5%，创下415.51美元的历史新高** 该股此前52周最高价为398美元** 这家制药巨头 (link) 周二晚间公布第二季度营收为101亿美元，远超华尔街预期的94.2亿美元** 第二季度调整后每股收益为6.29美元；据伦敦证券交易所集团（LSEG）汇编的数据，","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL4T4421SK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","LU2112291526.USD","LU1057294990.SGD","PJP","BK4588","SG9999001440.SGD","IBB","BK4533","LU0320765992.SGD","BBH","BK4534","LU1571399168.USD","LU1061106388.HKD","BK4566","LU0868494617.USD","LU1023059063.AUD","IE00BJT1NW94.SGD","BK4581","LU2242652126.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0289739699.SGD","BK4139","LU1983299246.USD","IE0002141913.USD","LU0058720904.USD","LU2468319806.SGD","LU2089984988.USD","TBXU","AMGN","BK4585","LU0889565916.HKD","IE0009355771.USD","LU0109394709.USD","PBE","LU0122379950.USD","IE00BFTCPJ56.SGD","BK4599","IBBQ","LU2242646821.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657142645","title":"券商觀點：吉利德艾滋病業務實力蓋過長期競爭擔憂","url":"https://stock-news.laohu8.com/highlight/detail?id=2657142645","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657142645?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 16:51","pubTimestamp":1785919863,"startTime":"0","endTime":"0","summary":"BUZZ-券商观点：吉利德艾滋病业务实力盖过长期竞争担忧8月5日-** 吉利德科学公司（GILD.O）周二公布（link），其第二季度产品销售额增长8%，主要得益于艾滋病治疗药物需求的强劲，但由于近期收购相关的费用，该公司报告了季度亏损** 该公司股价在盘前交易中微幅下跌艾滋病业务表现亮眼** Truist证券(“买入”评级，目标价：150美元) 表示，GILD的艾滋病业务线仍是持久的增长动力，且","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL4S4420SD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDI","BK4583","LU0882574055.USD","LU1571399168.USD","SG9999015952.SGD","BK4566","BK4585","TBXU","IBBQ","LU1057294990.SGD","LU1066051498.USD","BK4139","LU0058720904.USD","IE00BSNM7G36.USD","IE00B19Z3581.USD","LU0289739699.SGD","LU0114720955.EUR","LU2324357040.USD","LU0234570918.USD","TMED","LU1934455194.USD","BIB","LU0823416689.USD","LU1037948541.HKD","LU2468319806.SGD","LU0122379950.USD","IE00BKVL7J92.USD","LU2089984988.USD","LU0109394709.USD","BK4588","IE00BZ1G4Q59.USD","IBB","BK4532","LU2112291526.USD","BK4568","IE00B7SZLL34.SGD","SG9999015945.SGD","BK4578","BBH","LU1061106388.HKD","LU1778281490.HKD","LU0965509101.SGD","SG9999015978.USD","LU1585245621.USD","BMED","LU0965509283.SGD","IE00B19Z3B42.SGD","LU1674673428.USD","LU1674673691.USD","GILD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657511192","title":"行業觀察：安進憑藉重磅藥物、生物類似藥及蓄勢待發的研發管線持續積聚勢頭","url":"https://stock-news.laohu8.com/highlight/detail?id=2657511192","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657511192?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 16:24","pubTimestamp":1785918294,"startTime":"0","endTime":"0","summary":"BUZZ-行业观察：安进凭借重磅药物、生物类似药及蓄势待发的研发管线持续积聚势头8月5日-** 生物技术公司安进（Amgen）AMGN.O报告称，第二季度营收 (link) 增长了9%，这主要得益于其胆固醇治疗药物Repatha、骨质疏松症药物Evenity以及罕见病疗法的强劲需求，与此同时，该公司仍在继续推进其实验性减肥药MariTide的研发** 盘前交易中股价小幅上涨从研发到盈利** Tru","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL4S4420QV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU1057294990.SGD","IBBQ","BK4533","LU2242652126.USD","IE0009355771.USD","LU2468319806.SGD","LU0320765992.SGD","BK4581","BK4139","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU2089984988.USD","IE0002141913.USD","LU2112291526.USD","BK4534","LU1571399168.USD","IBB","BK4599","BK4566","IE00BJJMRZ35.SGD","BBH","LU1061106388.HKD","LU1023059063.AUD","SG9999001440.SGD","BIB","PBE","AMGN","LU0868494617.USD","IE00B4R5TH58.HKD","BK4588","IE00BFTCPJ56.SGD","TBXU","LU0109394709.USD","PJP","LU0122379950.USD","LU2242646821.SGD","LU0889565916.HKD","LU0289739699.SGD","LU1983299246.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108157113","title":"吉利德科學高管：Q2艾滋病治療市場趨軟，ACA税收補貼取消致部分民眾失去醫保覆蓋","url":"https://stock-news.laohu8.com/highlight/detail?id=1108157113","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108157113?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 05:32","pubTimestamp":1785879128,"startTime":"0","endTime":"0","summary":"吉利德科学（Gilead Sciences）高管在财报电话会议中透露，第二季度艾滋病治疗市场呈现疲软态势。究其原因，部分患者因《平价医疗法案》（ACA）税收补贴取消而失去保险计划，导致市场购买力下降，对整个行业形成冲击。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","LU0289739699.SGD","SG9999015945.SGD","IE00B3T34201.USD","BIB","LU0109394709.USD","LU1057294990.SGD","LU1778281490.HKD","LU2324357040.USD","BK4588","LU1061106388.HKD","LU0889565916.HKD","LU1674673691.USD","LU0320765992.SGD","LU1839511570.USD","BK4139","LU0234570918.USD","BMED","LU0122379950.USD","LU2087621335.USD","LU0965509101.SGD","IE0002270589.USD","LU1066053197.SGD","BK4585","SG9999015978.USD","SG9999015986.USD","LU0861579265.USD","LU1430594728.SGD","IE00BZ1G4Q59.USD","LU0965509010.AUD","LU2468319806.SGD","LU0058720904.USD","LU0882574055.USD","LU1934455863.HKD","LU0114720955.EUR","IE00BSNM7G36.USD","MEDI","TMED","LU0965509283.SGD","LU1066051498.USD","LU1934455277.USD","BK4532","IE00B19Z3581.USD","BK4568","IBB","LU0965508806.USD","LU1585245621.USD","TBXU","LU1037948541.HKD","LU1674673428.USD","LU1037948897.HKD","IBBQ","BBH","BK4578","LU2089984988.USD","LU2112291526.USD","BK4550","GILD","BK4566","SG9999015952.SGD","IE00B19Z3B42.SGD","LU1934455194.USD","LU1571399168.USD","IE00B7SZLL34.SGD","IE00BKVL7J92.USD","LU1023059063.AUD","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100032335","title":"吉利德科學高管：今年暫無計劃進行大規模併購交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1100032335","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100032335?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 05:12","pubTimestamp":1785877926,"startTime":"0","endTime":"0","summary":"吉利德科学公司高管在电话会议上表示，目前不预计今年会进行额外的大规模并购交易。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","LU1037948541.HKD","BK4532","BIB","IE00BSNM7G36.USD","LU1066051498.USD","LU0058720904.USD","SG9999015978.USD","IE00BKVL7J92.USD","IBB","IE00B19Z3B42.SGD","LU0965509101.SGD","BBH","LU1674673428.USD","BMED","LU1061106388.HKD","LU1934455277.USD","LU2089984988.USD","LU1674673691.USD","SG9999015952.SGD","TMED","LU1023059063.AUD","LU2324357040.USD","LU0965509283.SGD","IE00B3T34201.USD","IE00BZ1G4Q59.USD","BK4578","BK4588","BK4583","LU1778281490.HKD","BK4585","LU1839511570.USD","LU0122379950.USD","LU0965509010.AUD","LU1585245621.USD","LU1571399168.USD","LU1057294990.SGD","SG9999015986.USD","GILD","LU0234570918.USD","LU1934455194.USD","LU0882574055.USD","IBBQ","IE0002270589.USD","IE00B7SZLL34.SGD","LU1430594728.SGD","LU0889565916.HKD","LU0861579265.USD","LU2087621335.USD","LU1037948897.HKD","BK4568","LU1066053197.SGD","LU0289739699.SGD","TBXU","LU2112291526.USD","BK4566","LU0109394709.USD","LU0965508806.USD","LU0320765992.SGD","BK4139","BK4550","LU0114720955.EUR","LU1934455863.HKD","LU2468319806.SGD","MEDI","SG9999015945.SGD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657674945","title":"安進二季度強勁藥品銷售，上調預期，將終止早期減肥藥研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2657674945","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657674945?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 05:11","pubTimestamp":1785877860,"startTime":"0","endTime":"0","summary":"　　$安进$公司于周二美股收盘后公布财报，第二季度强劲药品销售提振公司利润，因此上调了全年预期，但同时表示将终止一款早期减肥疗法的开发。　　这家生物技术公司周二表示，将停止AMG 513的开发，这是一款目前处于1期研究阶段的潜在减肥疗法。安进称，该研究将完成以跟踪已入组受试者。　　随着AMG 513开发的终止，安进在该领域唯一的候选药物是MariTide，该药目前正在进行针对肥胖、2型糖尿病和慢性体重管理等适应症的3期研究。","market":"sg","thumbnail":"https://static.tigerbbs.com/e910a0d7e1da6d4a41f6d581ee31760f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e910a0d7e1da6d4a41f6d581ee31760f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-05/doc-inimezkz1673958.shtml","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CURE","LU0122379950.USD","RSPH","BIB","BK4533","BK4588","PJP","BK4566","IBB","AMGN","LU0320765992.SGD","THNR","TBXU","LU0058720904.USD","PINK","IYH","NBDS","PBE","BK4599","LU2468319806.SGD","IE00BJJMRZ35.SGD","TRUH","LU0289739699.SGD","BBH","IE00BJT1NW94.SGD","BK4139","LU1983299246.USD","IE00B2B36J28.USD","FXH","LU0889565916.HKD","IBBQ","LU0868494617.USD","NVOC","LU1023059063.AUD","BK4534","BK4581","IE0002141913.USD","XLVI","IE0009355771.USD","LU2242652126.USD","MEDI","LU1571399168.USD","LU1061106388.HKD","LU0109394709.USD","IE00B4R5TH58.HKD","LU2089984988.USD","SG9999001440.SGD","LU2242646821.SGD","FHLC","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657679605","title":"吉利德科學於2026年8月4日公布了2026年第二季度財務業績。總收入按年增長10%達到78億美元主要得益於不包括Vek","url":"https://stock-news.laohu8.com/highlight/detail?id=2657679605","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657679605?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 05:10","pubTimestamp":1785877839,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4583","IE0002270589.USD","LU0965509010.AUD","LU1057294990.SGD","IE00B7SZLL34.SGD","TBXU","BK4550","LU1061106388.HKD","LU1934455277.USD","LU0122379950.USD","LU0058720904.USD","IE00BZ1G4Q59.USD","LU0109394709.USD","LU1839511570.USD","LU1430594728.SGD","LU0965509283.SGD","LU2468319806.SGD","BBH","SG9999015986.USD","BMED","SG9999015978.USD","BK4585","IBB","IE00B19Z3B42.SGD","LU1674673428.USD","LU2324357040.USD","LU0882574055.USD","LU1037948541.HKD","BK4568","LU1066051498.USD","LU1778281490.HKD","LU1571399168.USD","IE00BKVL7J92.USD","BIB","LU0965508806.USD","LU2089984988.USD","TMED","LU0889565916.HKD","LU2087621335.USD","SG9999015952.SGD","LU0234570918.USD","LU1023059063.AUD","LU0114720955.EUR","LU0823416689.USD","IE00B19Z3581.USD","LU0861579265.USD","IBBQ","IE00BSNM7G36.USD","GILD","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657376567","title":"安進高管表示，預計第三季度運營支出將出現顯著的按月增長。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657376567","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657376567?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 05:02","pubTimestamp":1785877379,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4534","PBE","IE00B4R5TH58.HKD","LU1983299246.USD","LU0289739699.SGD","IE0009355771.USD","LU2242652126.USD","BK4139","LU0320765992.SGD","LU2242646821.SGD","BK4585","BK4581","LU1023059063.AUD","IE00BJJMRZ35.SGD","BK4588","LU2089984988.USD","LU1061106388.HKD","BK4533","LU0058720904.USD","BK4566","AMGN","SG9999001440.SGD","LU0109394709.USD","LU1057294990.SGD","TBXU","IBBQ","BIB","LU0868494617.USD","PJP","IE00B2B36J28.USD","IE00BJT1NW94.SGD","IE0002141913.USD","LU0889565916.HKD","BBH","IBB","LU0122379950.USD","BK4599","LU1571399168.USD","LU2112291526.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191538261","title":"安進高管重申：2026年資本支出預計約26億美元，用於擴大產能，含Maritide上市準備","url":"https://stock-news.laohu8.com/highlight/detail?id=1191538261","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191538261?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 05:01","pubTimestamp":1785877307,"startTime":"0","endTime":"0","summary":"安进高管最新表态，公司将继续维持2026年资本支出约26亿美元的预期。这笔资金的核心用途，正是为了扩大制造产能——其中，Maritide的上市准备工作尤为关键。\n26亿美元，一个庞大的数字，却承载着安进对未来市场的信心与布局。产能扩张，尤其是为Maritide的上市铺路，成为了这笔巨额支出的重中之重。这不仅仅是一次简单的投资，更是对战略产品线的全力押注。\n高管在发言中强调，该预期反映了公司对生产能力持续优化的坚定承诺。从长远来看，扩大制造规模不仅是为了满足现有产品的需求，更是为了确保Maritide等关键新药能够顺利推向市场。这一举措，无疑将为公司在竞争激烈的生物制药领域构筑更坚实的护城河。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","LU1023059063.AUD","IE00B2B36J28.USD","LU0122379950.USD","IE00B4R5TH58.HKD","LU0058720904.USD","BK4581","IE0009355771.USD","LU1571399168.USD","LU2242652126.USD","TBXU","LU2089984988.USD","LU2242646821.SGD","BK4585","LU1983299246.USD","LU2468319806.SGD","BK4533","LU0320765992.SGD","BK4599","IE00BJT1NW94.SGD","LU0868494617.USD","BK4534","LU1061106388.HKD","BK4139","LU0289739699.SGD","BK4566","BK4588","IBBQ","PJP","PBE","LU0889565916.HKD","BBH","LU1057294990.SGD","SG9999001440.SGD","IE0002141913.USD","LU2112291526.USD","BIB","AMGN","LU0109394709.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128189819","title":"安進高管：Q2資本支出達5億美元，聚焦全美製造基地投資——電話會議紀要","url":"https://stock-news.laohu8.com/highlight/detail?id=1128189819","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128189819?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 05:01","pubTimestamp":1785877299,"startTime":"0","endTime":"0","summary":"安进（Amgen）公司高管在电话会议中透露，第二季度资本支出高达5亿美元。这笔巨额投入的核心驱动力，正是该公司在全美多个制造基地进行的战略布局。投资浪潮席卷了美国的各个生产设施，从而推动了整体资本开支的显著增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","BIB","IE00BJT1NW94.SGD","PJP","IE0009355771.USD","BK4533","AMGN","IBB","LU0320765992.SGD","BK4581","PBE","TBXU","LU1983299246.USD","IE00B4R5TH58.HKD","SG9999001440.SGD","IE00B2B36J28.USD","LU2242646821.SGD","LU0889565916.HKD","LU1023059063.AUD","LU2089984988.USD","BK4139","LU2242652126.USD","LU2112291526.USD","LU0122379950.USD","LU1061106388.HKD","LU2468319806.SGD","LU0868494617.USD","BK4599","BK4534","IBBQ","LU1057294990.SGD","BK4566","BBH","BK4585","LU0289739699.SGD","LU1571399168.USD","LU0109394709.USD","IE00BFTCPJ56.SGD","BK4588","LU0058720904.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657562205","title":"安進高管在電話會議上表示，第二季度資本支出達5億美元，主要受美國各地生產基地投資推動。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657562205","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657562205?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 04:59","pubTimestamp":1785877188,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1057294990.SGD","BK4139","LU1983299246.USD","BK4566","IE0009355771.USD","AMGN","BBH","BK4588","LU0868494617.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU0122379950.USD","PJP","IE0002141913.USD","PBE","LU1023059063.AUD","LU0889565916.HKD","IE00B2B36J28.USD","BK4581","BK4533","FXR","LU0109394709.USD","LU2089984988.USD","LU2112291526.USD","DUSL","LU0289739699.SGD","LU2242652126.USD","LU2242646821.SGD","SG9999001440.SGD","BK4599","LU0320765992.SGD","LU1571399168.USD","IBBQ","TBXU","BIB","BK4534","LU0058720904.USD","BK4585","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","IBB","LU1061106388.HKD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135051692","title":"吉利德高管在電話會議中宣佈：全年HIV業務增長預期上調至9%-10%，此前指引為8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1135051692","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135051692?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 04:42","pubTimestamp":1785876147,"startTime":"0","endTime":"0","summary":"吉利德（Gilead Sciences）高管在电话会议上透露，公司已将全年HIV业务增长预期上调至9%至10%的区间。这一调整较此前8%的增长指引显著提升，展现了公司对该业务领域强劲势头的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","LU1023059063.AUD","IE00B7SZLL34.SGD","LU0965508806.USD","BIB","LU1674673428.USD","IBBQ","IE00B19Z3581.USD","LU1057294990.SGD","LU1037948541.HKD","LU0058720904.USD","LU0823416689.USD","LU1674673691.USD","LU1585245621.USD","LU1778281490.HKD","LU1839511570.USD","LU1934455194.USD","LU1037948897.HKD","LU2112291526.USD","SG9999015945.SGD","LU2324357040.USD","LU0965509283.SGD","LU1934455277.USD","SG9999015952.SGD","SG9999015986.USD","LU1571399168.USD","IE00B19Z3B42.SGD","BMED","LU0861579265.USD","BK4583","LU0965509010.AUD","LU0289739699.SGD","LU0114720955.EUR","IE00B3T34201.USD","LU0882574055.USD","BBH","BK4139","BK4566","BK4585","IE00BSNM7G36.USD","LU1061106388.HKD","IBB","LU1430594728.SGD","IE0002270589.USD","IE00BZ1G4Q59.USD","LU0234570918.USD","TBXU","GILD","SG9999015978.USD","LU0320765992.SGD","LU1066053197.SGD","BK4532","TMED","BK4578","LU1066051498.USD","LU0122379950.USD","LU1934455863.HKD","LU2468319806.SGD","BK4588","LU0965509101.SGD","LU0109394709.USD","LU0889565916.HKD","MEDI","LU2087621335.USD","LU2089984988.USD","BK4568","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145483121","title":"吉利德高管：距FDA PDUFA日期僅剩五個月，Anito-Cel細胞療法上市籌備工作已全面啓動","url":"https://stock-news.laohu8.com/highlight/detail?id=1145483121","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145483121?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 04:42","pubTimestamp":1785876146,"startTime":"0","endTime":"0","summary":"吉利德科学（Gilead Sciences）高管透露，针对其重磅细胞疗法Anito-Cel的上市准备工作已全面铺开，目前距离美国食品药品监督管理局（FDA）设定的PDUFA目标日期仅剩五个月时间。这一消息源自公司近期召开的电话会议。\n在会议中，高管进一步强调，公司正紧锣密鼓地推进各项筹备事项，以确保一旦获批，该疗法能够迅速进入市场。Anito-Cel作为一种前沿的细胞治疗产品，被视为吉利德在肿瘤学领域布局的关键一环。随着最终审批日期的临近，市场对这款疗法的商业化前景给予高度关注，而吉利德方面则展现出对既定时间表与执行能力的充分信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDI","BK4583","LU0882574055.USD","IE0002270589.USD","LU2087621335.USD","LU1037948897.HKD","LU1571399168.USD","SG9999015952.SGD","BK4566","BK4585","TBXU","LU0965509010.AUD","IBBQ","LU1057294990.SGD","LU1066051498.USD","LU1934455863.HKD","BK4139","LU0058720904.USD","IE00BSNM7G36.USD","IE00B19Z3581.USD","LU0289739699.SGD","LU0861579265.USD","LU0320765992.SGD","SG9999015986.USD","LU0114720955.EUR","LU0965508806.USD","IE00B3T34201.USD","LU0234570918.USD","LU2324357040.USD","TMED","BK4550","LU0889565916.HKD","BIB","LU0823416689.USD","LU1934455194.USD","LU1037948541.HKD","LU2468319806.SGD","LU1066053197.SGD","LU0122379950.USD","IE00BKVL7J92.USD","LU2089984988.USD","LU0109394709.USD","LU1934455277.USD","LU1839511570.USD","BK4588","IE00BZ1G4Q59.USD","IBB","BK4532","LU2112291526.USD","BK4568","IE00B7SZLL34.SGD","SG9999015945.SGD","BK4578","BBH","LU1061106388.HKD","LU1778281490.HKD","LU0965509101.SGD","LU1430594728.SGD","SG9999015978.USD","LU1585245621.USD","LU1023059063.AUD","BMED","LU0965509283.SGD","IE00B19Z3B42.SGD","LU1674673428.USD","LU1674673691.USD","GILD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163992816","title":"吉利德科學第二季度調整後每股收益-6.75美元，高於IBES預估-7.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1163992816","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163992816?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 04:17","pubTimestamp":1785874678,"startTime":"0","endTime":"0","summary":"8月4日，吉利德科学（Gilead Sciences）公布第二季度产品销售额达76.27亿美元。第二季度调整后每股收益为-6.75美元，优于IBES预估的-7.24美元。","market":"us","thumbnail":"https://static.tigerbbs.com/9e7ba54e8539d48dd315975babea7852","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/9e7ba54e8539d48dd315975babea7852"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","LU2087621335.USD","LU1839511570.USD","BK4578","LU0289739699.SGD","IE00B19Z3B42.SGD","IBB","IE00B3T34201.USD","IE00BKVL7J92.USD","LU0882574055.USD","LU0058720904.USD","BMED","LU1585245621.USD","LU2112291526.USD","TMED","SG9999015978.USD","LU1066051498.USD","LU0965509010.AUD","LU1934455194.USD","GILD","LU0889565916.HKD","SG9999015986.USD","LU1061106388.HKD","LU0114720955.EUR","LU1934455863.HKD","LU1037948541.HKD","LU0320765992.SGD","BK4566","BK4550","BK4568","LU0861579265.USD","LU1674673691.USD","LU1023059063.AUD","SG9999015945.SGD","LU1057294990.SGD","SG9999015952.SGD","IBBQ","BIB","LU1934455277.USD","TBXU","IE00B19Z3581.USD","LU0965509283.SGD","BK4532","LU0965508806.USD","LU1430594728.SGD","IE0002270589.USD","LU0109394709.USD","LU1571399168.USD","IE00B7SZLL34.SGD","LU2089984988.USD","BK4585","LU0234570918.USD","LU1066053197.SGD","IE00BZ1G4Q59.USD","LU1674673428.USD","BK4139","BK4583","IE00BSNM7G36.USD","MEDI","LU2468319806.SGD","LU0122379950.USD","LU0823416689.USD","LU2324357040.USD","BK4588","LU1037948897.HKD","LU0965509101.SGD","LU1778281490.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657627865","title":"安進(AMGN)股票8月4日收盤上漲3.03%：關鍵驅動因素揭曉","url":"https://stock-news.laohu8.com/highlight/detail?id=2657627865","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657627865?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 04:16","pubTimestamp":1785874591,"startTime":"0","endTime":"0","summary":"• 安进公布的第二季度业绩超出了市场对营收和每股收益的共识预期。\n• 一款代谢健康候选药物的积极中期临床数据推动了其股价上涨。\n• 全年营收达到367.5亿美元，该公司的净利润排名位列第十。","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262074405-market-movers-amgn-20260804","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","LU0320765992.SGD","IE00B4R5TH58.HKD","LU2242652126.USD","AMGN","LU2468319806.SGD","SG9999001440.SGD","LU1057294990.SGD","LU2089984988.USD","BK4566","LU0889565916.HKD","PJP","IBB","BBH","IE00BFTCPJ56.SGD","LU0289739699.SGD","LU1023059063.AUD","IBBQ","LU1061106388.HKD","LU0058720904.USD","LU2242646821.SGD","LU0868494617.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","IE00B2B36J28.USD","PBE","IE00BJT1NW94.SGD","LU2112291526.USD","LU0109394709.USD","TBXU","BK4139","IE0009355771.USD","BK4588","BK4599","BIB","BK4533","BK4581","LU1571399168.USD","BK4534","LU0122379950.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108344321","title":"吉利德科學：季度調整後每股虧損6.75美元，反映近期收購帶來的每股9.08美元知識產權研發及税務支出","url":"https://stock-news.laohu8.com/highlight/detail?id=1108344321","media":"美股速递","labels":["dataReport","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108344321?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 04:04","pubTimestamp":1785873878,"startTime":"0","endTime":"0","summary":"吉利德科学（Gilead Sciences）最新季度业绩揭晓。数据显示，公司调整后每股收益为-6.75美元。这一数字背后，折射出近期收购活动所产生的重大财务影响——具体而言，每股9.08美元的知识产权研发成本与税务费用被计入。这些支出，均与公司近期完成的收购交易紧密相关。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","SG9999015945.SGD","LU1934455863.HKD","LU0965509010.AUD","LU2324357040.USD","IE00B3T34201.USD","LU2089984988.USD","BK4568","LU2112291526.USD","LU0965509283.SGD","LU1571399168.USD","LU0320765992.SGD","IE00BZ1G4Q59.USD","BK4550","LU0882574055.USD","BK4532","BK4588","BK4583","IE00B19Z3581.USD","LU1674673691.USD","LU1061106388.HKD","MEDI","LU0109394709.USD","LU2468319806.SGD","TMED","LU1839511570.USD","LU1674673428.USD","IBBQ","BK4585","BMED","LU1066053197.SGD","IE00B19Z3B42.SGD","GILD","LU1066051498.USD","LU0122379950.USD","BBH","LU0058720904.USD","BK4566","LU1585245621.USD","IE0002270589.USD","IE00B7SZLL34.SGD","LU0289739699.SGD","LU0889565916.HKD","IE00BKVL7J92.USD","LU1778281490.HKD","TBXU","SG9999015978.USD","LU1430594728.SGD","LU0234570918.USD","SG9999015986.USD","LU0965508806.USD","LU1057294990.SGD","LU1037948541.HKD","LU1037948897.HKD","BK4139","LU1934455194.USD","LU0114720955.EUR","BK4578","LU0965509101.SGD","SG9999015952.SGD","IBB","LU0861579265.USD","BIB","LU1023059063.AUD","LU1934455277.USD","LU0823416689.USD","LU2087621335.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657569101","title":"安進第二季度銷售額增長9%，利潤超出華爾街預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2657569101","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657569101?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 04:04","pubTimestamp":1785873843,"startTime":"0","endTime":"0","summary":"安进第二季度销售额增长9%，利润超出华尔街预期经调整的每股收益为6.29美元，超出分析师预期上调全年营收和利润预期安进公司停止开发第二款实验性减肥药AMG 513Deena Beasley路透8月4日-安进公司周二公布，受降胆固醇药物Repatha、骨质疏松药物Evenity以及罕见病药物需求推动，第二季度销售额增长9%。季度营收同比增长10%，达到101亿美元，超过了华尔街94.2亿美元的平均预期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL4T4411XI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU0109394709.USD","LU0058720904.USD","LU2242652126.USD","SG9999001440.SGD","PJP","IBB","BK4566","LU2112291526.USD","BK4139","LU2242646821.SGD","BK4599","LU1023059063.AUD","BK4533","LU0320765992.SGD","LU1983299246.USD","PBE","LU0889565916.HKD","BIB","TBXU","LU0289739699.SGD","LU1061106388.HKD","BK4534","AMGN","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4585","LU2468319806.SGD","IBBQ","BBH","BK4588","IE0009355771.USD","LU0868494617.USD","LU1571399168.USD","IE00BJT1NW94.SGD","LU0122379950.USD","BK4581","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","04332","LU1057294990.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657820569","title":"吉利德第二季度銷售額增長8%，超出華爾街預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2657820569","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657820569?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 04:02","pubTimestamp":1785873759,"startTime":"0","endTime":"0","summary":"据LSEG数据显示，该公司总营收增长10%至78亿美元，超出华尔街预期的74亿美元。第二季度，吉利德公布经调整后每股亏损为6.75美元，而华尔街分析师平均预期为7.24美元。另一款较早上市的艾滋病口服药Descovy的季度销售额猛增48%，达到9.67亿美元，增幅超出预期。吉利德表示，其肝病产品组合的销售额增长10%，达到8.77亿美元，而细胞疗法产品的销售额则下降14%，至4.17亿美元，这反映出市场竞争加剧。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL4T4411XD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDI","LU2468319806.SGD","BMED","LU1778281490.HKD","LU2089984988.USD","GILD","LU0965509010.AUD","LU0965509283.SGD","LU1037948897.HKD","IBB","SG9999015986.USD","LU0965508806.USD","LU0823416689.USD","LU1585245621.USD","IE00B19Z3581.USD","LU1066053197.SGD","SG9999015945.SGD","IE00BZ1G4Q59.USD","LU2112291526.USD","LU1934455277.USD","LU1066051498.USD","LU0058720904.USD","IE00B3T34201.USD","BK4583","LU1571399168.USD","LU0320765992.SGD","LU0109394709.USD","BK4566","BK4588","LU0882574055.USD","SG9999015978.USD","LU1674673428.USD","LU0289739699.SGD","LU0965509101.SGD","IE00B19Z3B42.SGD","LU2324357040.USD","LU0889565916.HKD","BIB","BK4139","BBH","BK4585","SG9999015952.SGD","TBXU","IBBQ","BK4568","IE00BSNM7G36.USD","LU0114720955.EUR","LU1061106388.HKD","TMED","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":5,"totalSize":153,"code":"91000000","status":"200"}]}}